New Epidemiological Insights into Mydriasis Reveal Projected Increase in Eye Exams and Surgeries Through 2034Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Prader-Willi Syndrome - Epidemiology ...

A recent epidemiology forecast provides an extensive review of Prader-Willi Syndrome (PWS), projecting the evolution of the disease through 2034. This report intends to furnish healthcare ...

The new Prescription Drug User Fee Act (PDUFA) date for diazoxide choline extended-release (DCCR) is slated for 27 March 2025 ...

Soleno Therapeutics ( NASDAQ: SLNO) fell about 17% in premarket trading after the U.S. FDA extended the review period for its ...

Katie Price revealed her eldest son Harvey sent her an emotional message in the run-up to Christmas as he shared what he is ...

DelveInsight’s "Prader–Willi Syndrome Market Insights, Epidemiology, and Market Forecast – 2034" report delivers an in-depth ...

The Forest Park Police Department is searching for a missing woman with developmental disabilities. Police said Victoria ...

Acadia is on track to achieve over $1 billion in annualized sales in 2025. The next phase of growth could come from two ...

A mother from Kent is launching a foundation in memory of her son to help others with disabilities learn high-end ...

This medication is intended for the treatment of Prader-Willi syndrome (PWS) in individuals aged four years and older who experience hyperphagia, a condition characterized by persistent ...

Soleno submitted the NDA to the FDA on June 27, 2024. The FDA accepted the NDA and granted Priority Review in August 2024. Diazoxide choline has been granted Breakthrough and Fast Track Designations ...